Memphis Pharmaceuticals (MPCI.CA) - Board of Directors' Decisions
Company Name : Memphis Pharmaceuticals
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
The Board of Directors' decisions held on 28/01/2026 including the unaudited financial results for the ended period on 31/12/2025.
The BoD Decisions (1,818 KB)
The Audit Committee Meeting Minutes (2,796 KB)
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
The Board of Directors' decisions held on 28/01/2026 including the unaudited financial results for the ended period on 31/12/2025.
The BoD Decisions (1,818 KB)
The Audit Committee Meeting Minutes (2,796 KB)
Comments